Form D — Cantai Therapeutics, Inc.
0001991732-25-000002 · filed 2025-07-15
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $1,100,000
- Total sold
- $550,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cantai Therapeutics, Inc.
- CIK
- 1991732
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 3675 MARKET STREET
PHILADELPIA, PA 19104 - Phone
- 603-996-1218
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ross Leimberg · Executive OfficerPhiladelphia, PA Find on LinkedIn ↗
-
Errik Anderson · Executive OfficerPhiladelphia, PA Find on LinkedIn ↗
-
Geeta Vemuri · Executive OfficerPhiladelphia, PA Find on LinkedIn ↗
-
Joshua Brandt · DirectorPhiladelphia, PA Find on LinkedIn ↗
View original on SEC EDGAR.